Latest phenytoin Stories
New research from the Emory University School of Medicine offers reassurance for nursing mothers with epilepsy.
There's good news for women with epilepsy.
A large population-based study revealed that multiple antiepileptic drugs (AEDs) used by pregnant women to control seizures may cause poor school performance in their teenagers.
A dozen new epilepsy drugs are giving doctors and patients more options, but making treatment decisions more complex, a Loyola epilepsy specialist reports in the journal Neurologic Clinics.
NEW YORK, Oct. 11 /PRNewswire/ -- Attorney Keith Jensen of the Fort Worth, Texas-based law firm of Jensen, Belew & Gonzalez is announcing a $3.78 million settlement with pharmaceutical manufacturer Pfizer Inc.
While the Food and Drug Administration (FDA) requires a warning of an increased risk of suicide for all epilepsy drugs, a new study shows that only certain drugs may increase the risk.
ATLANTA, June 29 /PRNewswire/ -- New long term data showed that VimpatÂ® (lacosamide) C-V provided sustained reduction in seizure frequency for up to five years when used as an add-on treatment for uncontrolled partial onset seizures in adults with epilepsy.
Phenytoin is a well known antiepileptic agent widely used throughout the world.
ATLANTA, March 11 /PRNewswire/ -- UCB today announced that the antiepileptic drug (AED) VimpatÂ® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia. This study was one of three that supported the approval of Vimpat by the U.S.
New guidelines developed by the American Academy of Neurology and the American Epilepsy Society show it's relatively safe for women with epilepsy to become pregnant, but caution must be taken, including avoiding one particular epilepsy drug that can cause birth defects.
- totally perplexed and mixed up.